Safety and effectiveness of apixaban in comparison to warfarin in patients with nonvalvular atrial fibrillation: a propensity-matched analysis from Japanese administrative claims data

DOI Web Site 1 Citations
  • Shun Kohsaka
    Department of Cardiology, Keio University School of Medicine, Tokyo, Japan;
  • Jun Katada
    Pfizer Japan Inc., Tokyo, Japan;
  • Kumiko Saito
    Bristol-Myers Squibb K.K., Tokyo, Japan;
  • Yasuo Terayama
    Department of Gerontology, School of Medicine, Iwate Medical University, Iwate, Japan

Journal

Citations (1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top